Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

BackgroundThe nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risks in the general population. Patients with rheumatoid arthritis (RA) carry an excess risk for CVD....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yao-Wei Zou, Qian-Hua Li, Jing-Wei Gao, Jie Pan, Jian-Da Ma, Le-Feng Chen, Jian-Zi Lin, Ying-Qian Mo, Xue-Pei Zhang, Pin-Ming Liu, Lie Dai
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2022-05-01
Sarja:Frontiers in Cardiovascular Medicine
Aiheet:
cardiovascular disease
rheumatoid arthritis
metabolic dysfunction-associated fatty liver disease
non-alcoholic fatty liver disease
inflammation
Linkit:https://www.frontiersin.org/articles/10.3389/fcvm.2022.884636/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia